Sera Prognostics Files Definitive Proxy Statement

Ticker: SERA · Form: DEF 14A · Filed: Apr 23, 2025 · CIK: 1534969

Sentiment: neutral

Topics: proxy-statement, governance, shareholder-meeting

TL;DR

Sera Prognostics DEF 14A filed. Annual meeting June 5th. Vote on directors & pay.

AI Summary

Sera Prognostics, Inc. filed its definitive proxy statement on April 23, 2025, for its annual meeting on June 5, 2025. The filing outlines the company's governance and proposals to be voted on by shareholders, including the election of directors and executive compensation.

Why It Matters

This filing provides shareholders with crucial information regarding company leadership and voting matters, impacting their ability to make informed decisions about the company's future direction.

Risk Assessment

Risk Level: low — This is a routine proxy filing detailing governance and shareholder votes, not indicating immediate financial distress or significant operational changes.

Key Numbers

Key Players & Entities

FAQ

What is the purpose of a DEF 14A filing?

A DEF 14A filing, or definitive proxy statement, is used by companies to solicit shareholder votes on important matters such as the election of directors, executive compensation, and other corporate actions.

Who is the filing company?

The filing company is SERA PROGNOSTICS, INC.

When was this filing made?

This definitive proxy statement was filed on April 23, 2025.

When is the scheduled annual meeting?

The annual meeting is scheduled for June 5, 2025.

What is the company's primary business?

SERA PROGNOSTICS, INC. is in the business of Medical Laboratories, with SIC code 8071.

Filing Details

This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 23, 2025 regarding SERA PROGNOSTICS, INC. (SERA).

View full filing on EDGAR

View Full Filing

View this DEF 14A filing on SEC EDGAR

View on Read The Filing